FDA Label for Mucosa Guifenesin

View Indications, Usage & Precautions

Mucosa Guifenesin Product Label

The following document was submitted to the FDA by the labeler of this product Magno-humphries, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredient (In Each Tablet)



Guaifenesin 400 mg


Purpose



Expectorant


Uses



  • helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive to rid the bronchial passageway of bothersome mucus

Warnings




Ask A Doctor Before Use If You Have



  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by excessive phlegm (mucus)

When Using This Product



  • do not exceed recommended dosage
  • do not use for more than 7 days

Stop Use And Ask A Doctor If



  • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

If Pregnant Or Breast-Feeding,



ask a health professional before use.


Keep Out Of Reach Of Children.



In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.


Directions



 Adults and children 12 years of age and older: Take one tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 doses in 24 hours.
 Children under 12 years of age: Do not use


Other Information



  • store at controlled room temperature 15° to 30°C (59° to 86°F)

Inactive Ingredients



croscarmellose sodium, dicalcium phosphate, microcrystalline cellulose, silicon dioxide, stearic acid.


Questions?



call toll-free 1-800-935-6737


Package Labeling:




* Please review the disclaimer below.